Predicting Adverse Drug Reactions Early: A Closer Look at the InVEST44™ Profiling Panel by Evelyn Ma | Feb 11, 2025
The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models. Cancer Research Communications, 2022 by Andrew Khouri | Jul 6, 2023
